icad inc (NASDAQ:ICAD) — Market Cap & Net Worth
Market Cap & Net Worth: icad inc (ICAD)
icad inc (NASDAQ:ICAD) has a market capitalization of $106.31 Million ($106.31 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19061 globally and #4402 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying icad inc's stock price $3.87 by its total outstanding shares 27470900 (27.47 Million). Also see ICAD total assets for a full breakdown of the balance sheet.
icad inc Market Cap History: 2015 to 2025
icad inc's market capitalization history from 2015 to 2025. Data shows change from $142.02 Million to $106.31 Million (-0.41% CAGR). Also see icad inc (ICAD) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
icad inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #543 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1844 of 3165 |
Weight: icad inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
icad inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how icad inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check icad inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.56x
icad inc's market cap is 2.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $142.02 Million | $41.55 Million | -$32.45 Million | 3.42x | N/A |
| 2016 | $88.87 Million | $26.34 Million | -$10.10 Million | 3.37x | N/A |
| 2017 | $94.50 Million | $28.10 Million | -$14.26 Million | 3.36x | N/A |
| 2018 | $101.64 Million | $25.62 Million | -$9.02 Million | 3.97x | N/A |
| 2019 | $213.45 Million | $31.34 Million | -$13.55 Million | 6.81x | N/A |
| 2020 | $362.62 Million | $29.70 Million | -$17.61 Million | 12.21x | N/A |
| 2021 | $197.79 Million | $33.64 Million | -$11.24 Million | 5.88x | N/A |
| 2022 | $50.27 Million | $27.94 Million | -$13.66 Million | 1.80x | N/A |
| 2023 | $48.62 Million | $17.32 Million | -$4.85 Million | 2.81x | N/A |
| 2024 | $50.27 Million | $19.61 Million | -$5.62 Million | 2.56x | N/A |
Competitor Companies of ICAD by Market Capitalization
Companies near icad inc in the global market cap rankings as of September 18, 2026. Review ICAD tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to icad inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
icad inc Historical Marketcap From 2015 to 2025
Between 2015 and today, icad inc's market cap moved from $142.02 Million to $ 106.31 Million, with a yearly change of -0.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $106.31 Million | +111.48% |
| 2024 | $50.27 Million | +3.39% |
| 2023 | $48.62 Million | -3.28% |
| 2022 | $50.27 Million | -74.58% |
| 2021 | $197.79 Million | -45.45% |
| 2020 | $362.62 Million | +69.88% |
| 2019 | $213.45 Million | +110.00% |
| 2018 | $101.64 Million | +7.56% |
| 2017 | $94.50 Million | +6.34% |
| 2016 | $88.87 Million | -37.43% |
| 2015 | $142.02 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 15th, 2026 the market cap of icad inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $106.31 Million USD |
| MoneyControl | $106.31 Million USD |
| MarketWatch | $106.31 Million USD |
| marketcap.company | $106.31 Million USD |
| Reuters | $106.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About icad inc
iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurat… Read more